Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.
D000483:Alleles; D045744:Cell Line, Tumor; D004198:Disease Susceptibility; D015870:Gene Expression / Q000235:genetics*; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics* / Q000378:metabolism; D008156:Luciferases / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism; D008969:Molecular Sequence Data; D009103:Multiple Sclerosis / Q000235:genetics*; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000096:biosynthesis; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D018709:Statistics, Nonparametric; D013997:Time Factors; D015533:Transcriptional Activation; D014162:Transfection
D007376:Interleukin-2; D012333:RNA, Messenger; D008156:Luciferases